RxDoctor Payments Data

Michael Doany, MD

Orthopaedic Surgery · Stony Brook, NYNPI 1609370824

Payments from drug & device makers

What this record shows

This record is dominated by grants: $20,000 of the $29,347 with a category attached, or 68.1%. Smith+Nephew accounts for 68.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $21,705 and has fallen 95.4% since, to $1,003 in 2025.

$29,347in general payments, 2019–2025

Across 83 payments — averaging $353.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$20K
  • Gotham Surgical Solutions & Devices, Inc.$4K
  • Stryker$3K
  • Medacta USA, Inc.$1K
  • Johnson & Johnson$582
  • Illuminoss Medical, Inc.$368
  • plus $796 from 8 others

What the payments were for

  • Grants$20,00068%
  • Travel & lodging$1,3415%
  • Food & beverage$4,40615%
  • Education$3,60012%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,347 in reported general payments places this provider in the 80th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$71,043
Medicare patients
81
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Stony Brook

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →